Sarepta Moves Closer to Full Approval for Two Key Duchenne Muscular Dystrophy Drugs
Sarepta DMD drugs AMONDYS 45 and VYONDYS 53 near full FDA approval; decision due Feb 2027.
Already have an account? Sign in.
Sarepta DMD drugs AMONDYS 45 and VYONDYS 53 near full FDA approval; decision due Feb 2027.
SpaceX’s Starship upper stage returned from a 22-hour orbital mission and was caught by the launch tower for the first time, marking a key reusability milestone.
The Financial Times reports Amazon is the hyperscaler behind Fermi America’s new 600 MW power deals following the breakdown of 2025 talks.
Meta’s internal prediction market app Takes lets employees bet with credibility points instead of cash. Launch plans remain unclear.
Be the first to know when deals break, stocks move, or biotech headlines hit.